The prognostic role of LAG-3 expression in metastatic colorectal cancer

被引：1
|
作者：
Huang, Y-H. [1 ]
Lee, C-T. [2 ]
Lin, P. C. [1 ]
Chan, R-H. [3 ]
Chen, P-C. [3 ]
Lin, B-W. [3 ]
Shen, M-R. [4 ]
Chen, S-H. [5 ]
Yeh, Y-M. [1 ]
机构：
[1] NCKUH Natl Cheng Kung Univ Hosp, Dept Oncol, Tainan, Taiwan
[2] NCKUH Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan
[3] NCKUH Natl Cheng Kung Univ Hosp, Dept Surg, Tainan, Taiwan
[4] NCKUH Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan, Taiwan
[5] Natl Hlth Res Inst, Natl Inst Canc Res, NIH, Tainan, Taiwan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.249
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114P
引用
收藏
页码：S1514 / S1515
页数：2
相关论文
共 50 条
  • [41] Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma
    Yao, X. M.
    Zhang, F. H.
    Liu, Y.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 174 (06) : 774 - 778
  • [42] Clinicopathological significance and prognostic role of LAG3+tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness
    Tavana, Shirin
    Mokhtari, Zahra
    Sanei, Mohammad Hossein
    Heidari, Zahra
    Dehghanian, Amir-Reza
    Faghih, Zahra
    Rezaei, Marzieh
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [43] LAG-3 expression in advanced basal cell carcinoma (BCC) and tumor regression following combined PD-1/LAG-3 blockade
    Deutsch, J. S.
    Schenk, K. M.
    Soni, A.
    Lipson, E.
    Taube, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S271 - S271
  • [44] Role of the Modified Glasgow Prognostic Score (mGPS) as a Prognostic Factor in Metastatic Colorectal Cancer
    Cotan, Horia
    Iaciu, Cristian
    Nitipir, Cornelia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [45] Development of LAG-3 nanobodies as potent cancer imaging tracers
    Lecocq, Q.
    Awad, R. M.
    Zeven, K.
    De Vlaeminck, Y.
    de Mey, W.
    Debie, P.
    Puttemans, J.
    Goyvaerts, C.
    Raes, G.
    Keyaerts, M.
    Devoogdt, N.
    Breckpot, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] PD-L1, LAG-3, and GAL-3 Expression in Mismatch Repair Deficient and Intact Colorectal Carcinomas
    Ju, Jennifer
    Mills, Anne
    Stelow, Edward
    MODERN PATHOLOGY, 2019, 32
  • [47] Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
    Magri, Valentina
    Marino, Luca
    Nicolazzo, Chiara
    Gradilone, Angela
    De Renzi, Gianluigi
    De Meo, Michela
    Gandini, Orietta
    Sabatini, Arianna
    Santini, Daniele
    Cortesi, Enrico
    Gazzaniga, Paola
    CELLS, 2023, 12 (08)
  • [48] The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib
    Yekeduz, Emre
    Aktas, Elif Gizem
    Koksoy, Elif Berna
    Dogan, Neslihan
    Urun, Yuksel
    Utkan, Gungor
    FUTURE ONCOLOGY, 2022, 18 (09) : 1067 - 1076
  • [49] Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer
    Schirripa, Marta
    Cremolini, Chiara
    Loupakis, Fotios
    Morvillo, Manfredi
    Bergamo, Francesca
    Zoratto, Federica
    Salvatore, Lisa
    Antoniotti, Carlotta
    Marmorino, Federica
    Sensi, Elisa
    Lupi, Cristiana
    Fontanini, Gabriella
    De Gregorio, Veronica
    Giannini, Riccardo
    Basolo, Fulvio
    Masi, Gianluca
    Falcone, Alfredo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (01) : 83 - 90
  • [50] The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer
    Basile, D.
    Lisanti, C.
    Borghi, M.
    Bartoletti, M.
    Gerratana, L.
    Bortot, L.
    Pelizzari, G.
    Corvaja, C.
    Ongaro, E.
    Garattini, S. K.
    Fanotto, V.
    Parnofiello, A.
    Cortiula, F.
    Cattaneo, M.
    Andreotti, V. J.
    Bertoli, E.
    Guardascione, M.
    Miolo, G.
    Puglisi, F.
    Buonadonna, A.
    ANNALS OF ONCOLOGY, 2018, 29
12345